This is a randomized, crossover study enrolling experienced dual cannabis-tobacco smokers (N=18) to describe the differences in THC and toxicant exposure, examining pharmacokinetic, subjective, and cardiovascular effects from smoking and vaping dry herb cannabis. This study will also examine the differences in toxicant exposure and cardiovascular disease risk between smoking cannabis and smoking tobacco cigarettes.
Age range
21 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Peak plasma concentration
Timeframe: Day 1 of each arm
Time to peak plasma concentration
Timeframe: Day 1 of each arm
Area under the plasma concentration versus time curve (AUC)
Timeframe: Day 1 of each arm
Subjective effects between cannabis products using the Marijuana Cravings Questionnaire
Timeframe: Days 1-2 of each arm
Subjective effects between cannabis products using the Visual Analog Scale
Timeframe: Days 1-2 of each arm
Subjective effects between cannabis products using the Drug Effects Questionnaire
Timeframe: Days 1-2 of each arm
Max change of expired carbon monoxide
Timeframe: Days 1-2 of the cannabis arms
Area under the expired carbon monoxide (CO) curve (AUC)
Timeframe: Days 1-2 of the cannabis arms
Differences in metabolites of volatile organic compounds (VOCs)
Timeframe: Days 1-2 of the cannabis arms
Exposure to toxicants between cannabis products
Timeframe: Days 1-2 of the cannabis arms
Cardiovascular effects between cannabis products using heart rate as a measure
Timeframe: Day 1 of each arm
Cardiovascular effects between cannabis products using epinephrine as a measure
Timeframe: Day 2 of each cannabis arm
Cardiovascular effects between cannabis products using platelet activation as a measure
Timeframe: Day 2 of each cannabis arm
Cardiovascular effects between cannabis products using oxidant stress as a measure
Timeframe: Day 2 of each cannabis arm
Cardiovascular effects between cannabis products using endothelial dysfunction as a measure
Timeframe: Day 2 of each cannabis arm